Heat map: 5 top nanomedicine startups
RS Research was named one of the “5 Top Nanomedicine Startups Impacting The Healthcare Industry” by StartUs Insights
About RS Research
This author has not written his bio yet.
But we are proud to say that RS Research contributed 66 entries already.
Entries by RS Research
TURKISH POLICY QUARTERLY
Interview with Rana Sanyal: The Future of Nanomedicines
DUNYA
Three Turkish start-ups to qualify for finals in Paris
CLEANROOM NEWS
Turkey’s healthcare awards
PHARMA TURKEY
Big Business Through Cultural Cooperation Between Turkey and The US: “Move Turkey To Forward in Health
MEDIKAL NEWS
Move Turkey Forward in Healthcare with 100-billion-dollar trade capacity target
TURKIYE
Turkish signature for cancer drug
DUNYA
US-Turkey healthcare collaboration depends on the ecosystem
THE TURKISH PERSPECTIVE
VC Funded RS Research starting Clinical Trials
SABAH
Producing a sniper drug hunting cancer
RS Research is a clinically-validated biotech company developing targeted oncology therapies using Sagitta® drug-delivery platforms, disrupting the efficacy-toxicity trade-off.
